MedTrace Logo

Vascular and Lipid Effects of Omega-3 Fatty Acids in People With Moderately Elevated Triglycerides

NCT00504309 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 28

Last updated 2018-03-13

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to evaluate the cardiovascular and lipid effects of two doses of an omega-3 fatty acid concentrate in a group of people who normally are not treated for high lipids.

Conditions

  • Hypertriglyceridemia

Interventions

DRUG

4/day of 4g P-OM3 capsules

4/day of 4g P-OM3 capsules for 8 weeks

DRUG

4/day of 1g P-OM3 capsules

4/day of 1g P-OM3 capsules for 8 weeks

DRUG

Corn Oil Placebo, 4 capsules/day for 8 weeks

4 capsules per day of corn oil placebo for 8 weeks

Sponsors & Collaborators

  • Reliant Pharmaceuticals

    collaborator INDUSTRY

  • Penn State University

    lead OTHER

Principal Investigators

  • Sheila G West, PhD · Penn State University

  • Penny M Kris-Etherton, PhD · Penn State University

  • Ann C Skulas-Ray, B.S. · Penn State University

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
DOUBLE
Model
CROSSOVER

Eligibility

Min Age
21 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-07-31
Primary Completion
2009-01-31
Completion
2009-01-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00504309 on ClinicalTrials.gov